test

Justin Hirsch

@Octagon Capital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$642.902MTotal holdings41
Assets growth rate1.05%Assets growth rate (2-Q avg)-11.35%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Octagon Capital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Octagon Capital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 642.902M in assets, with a quarterly growth rate of 1.05% and a 2-quarter average growth rate of -11.35%. The portfolio is managed by Justin Hirsch, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TERNTerns Pharmaceuticals Inc
Recent Activity
Exited
0%
$9.292M
1.364M shares@ $6.81 avg price
ANTXAn2 Therapeutics Inc
Recent Activity
Exited
0%
$6.924M
3.22M shares@ $2.15 avg price
AKROAkero Therapeutics Inc
Recent Activity
Exited
0%
$6.648M
283,372 shares@ $23.46 avg price
JSPRJasper Therapeutics Inc
Recent Activity
Exited
0%
$6.526M
287,500 shares@ $22.7 avg price
CYBNCybin Inc
Recent Activity
Exited
0%
$5.042M
18.605M shares@ $0.28 avg price
SLNSilence Therapeutics Plc
Recent Activity
Exited
0%
$3.344M
176,000 shares@ $19.0 avg price
PSTXPoseida Therapeutics Inc
Recent Activity
Exited
0%
$2.149M
736,000 shares@ $2.92 avg price
ELEVElevation Oncology Inc
Recent Activity
Exited
0%
$2.017M
747,000 shares@ $2.7 avg price
FATEFate Therapeutics Inc
Recent Activity
Exited
0%
$1.708M
520,800 shares@ $3.28 avg price
ACETAdicet Bio Inc
Recent Activity
Exited
0%
$929,037
767,799 shares@ $1.22 avg price